EC Number   |
Title |
Organism |
|---|
   1.3.99.5 | Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin |
Mus musculus |
| 1.3.99.5 | Self-organizing molecular field analysis on pregnane derivatives as human steroidal 5alpha-reductase inhibitors |
Homo sapiens |
| 1.3.99.5 | Significant impact of 5alpha-reductase type 2 polymorphisms on sperm concentration and motility |
Homo sapiens |
| 1.3.99.5 | Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis |
Homo sapiens |
| 1.3.99.5 | Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer |
Homo sapiens |
| 1.3.99.5 | Structure and catalytic mechanism of 3-ketosteroid-DELTA4-(5alpha)-dehydrogenase from Rhodococcus jostii RHA1 genome |
Rhodococcus jostii |
| 1.3.99.5 | Synthesis of pregnane derivatives, their cytotoxicity on LNCap and PC-3 cells, and screening on 5alpha-reductase inhibitory activity |
Homo sapiens |
| 1.3.99.5 | Testosterone selectively affects aromatase and 5alpha-reductase activities in the green anole lizard brain |
Anolis carolinensis |
| 1.3.99.5 | The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men |
Homo sapiens |
| 1.3.99.5 | The effects of the dual 5alpha-reductase inhibitor dutasteride on localized prostate cancer - results from a 4-month pre-radical prostatectomy study |
Homo sapiens |
